The Chiari Malformation Market segment is fundamentally structured by diagnostic methods, treatment type, and end-user. By Diagnostic Method, the market is divided into Imaging (MRI, CT) and Neurological Assessments, with advanced MRI and CSF flow studies driving the highest value segment. Treatment Type segmentation is crucial, separating the market into Surgical Treatment (Posterior Fossa Decompression) and Symptomatic Pharmaceutical Management (Pain and Anti-inflammatory Drugs). The Surgical segment, encompassing devices and operating room costs, is the overwhelming driver of market revenue.

The Surgical Treatment segment is further segmented by the procedure's specific approach (e.g., bone-only vs. duraplasty), which influences the demand for products like specialized high-speed drills and dural substitutes. End-user segmentation includes Hospitals (where all surgeries are performed) and Specialty Clinics. Hospitals, particularly those with dedicated neurosurgery departments and advanced imaging centers, dominate the market share. The market's high value is thus concentrated in the sales of specialized neurosurgical devices and the high procedural fees associated with complex, life-altering neuro-structural repair.